| John Lehmann Ph.D. | | |
| | |
| Toxicology Consultant / Neurotoxicology / Pharmacology Expert Witness |
| | |
| Areas of Toxicology Expertise: |
| | - Causation of Brain and Spine Injury and Death, Respiratory Depression, Drug-Induced Memory Impairment
- Neurotoxicity, Biochemistry and Neurochemistry of Stroke, Traumatic Brain Injury, Hypoxia-induced Brain Damage, Neuro Toxicology, Neuropharmacology Consultant
- Design and Conduct of Clinical Trials, Label Development
- Adequacy of Warning to Physician Learned Intermediary in Medical Malpractice Issues
- Analysis of NDA, IND, PSUR, label revisions, Investigators' Brochure, other FDA documentation
- Antiepileptics, Antidepressants
- Due Diligence by Liability Insurance Carriers of Pharmaceutical Corporations
- Investment Analysis of Pharmaceutical Corporations - Product Liability Risk Exposure
- Managed Care Patient Registry Statistical Analysis (Pharmetrics Database, IMS Health Data)
|
| Description: |
| | 10 years experience as Research Pharmacologist in Pharmaceutical Industry in Drug Discovery in the United States & France; 10 years Faculty in Medical School, Departments of Psychiatry and Neurosurgery, PI of Clinical Trials; Independent Toxicology Consultant / Neuropharmacology Consultant / Pharmacology Consultant for 4 years. 20 years experience in Neurotoxicology / Neurotoxicity Research; Published over 60 peer-reviewed papers. |
| Contact information |
| | John Lehmann Ph.D. Pharmikos Inc Homepage:http://rtctox.com/lehmann.htm Website: http://pharmikos.com | |
| Professional Society Membership: |
| | |
| | |
| Publications: |
| | 86 peer-reviewed papers and chapters available upon request. |
| | Lehmann J, Arbilla S, Langer SZ. Dopamine receptor mediated inhibition by Pergolide [Permax] of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate. Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):31-5 |
| | Lehmann J, Langer SZ. Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine. Brain Res. 1982 Sep 23;248(1):61-9. |
| | |
| | |
| Dictionary of Abbreviations and Acronyms used |
| Fda | Food and Drug Administration Fda Toxicology Consultant |
| Ind | Investigational New Drug | |
| NDA | New Drug Application | |
| Ntd | NeuroToxicology Division | |
| Pi | Principal Investigator | |
| Psur | Periodic Safety Update and Review | |
| Sot | Society of Toxicology Expert Witness | |
| Sas | Statistical Analysis Software | |